Alex Azar II reports an option exercise at Guardant Health
By AlphaYouPublished Form 4
Azar Alex M II
Reporting filer
Alex Azar II reports an option exercise, not an open-market purchase or sale, in Guardant Health, Inc.. Form 4 filed Oct 13, 2026 lists 2 entries.
- Disclosed
- Oct 13, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Azar Alex M II | 2026-10-12 | M | Exercise or conversion | 137 | 0 | 962 | 1 day | Filed terms
|
| Restricted Stock Units (derivative) | Azar Alex M II | 2026-10-12 | M | Exercise or conversion | 137 | 0 | 4,816 | 1 day | Filed terms
|
Common Stock
- Owner
- Azar Alex M II
- Date
- 2026-10-12
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 137
- Price
- 0
- Following holdings
- 962
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-12
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 137
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 962
- direct Or Indirect Ownership: D
Restricted Stock Units (derivative)
- Owner
- Azar Alex M II
- Date
- 2026-10-12
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 137
- Price
- 0
- Following holdings
- 4,816
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Restricted Stock Units
- conversion Or Exercise Price: 0
- transaction Date: 2026-10-12
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 137
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F1
- id: F2
- underlying Security Title: Common Stock
- underlying Security Shares: 137
- shares Owned Following Transaction: 4816
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Azar Alex M II: Director.
- F1: The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award vested on September 12, 2026 and the remaining 75% vests monthly for the three-year period thereafter.
- F2: Not applicable for Restricted Stock Units.
Original sources
Prepared automatically from public filing data. Report a correction.